Masamune Hiroko 4
4 · Viking Therapeutics, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Masamune Hiroko
Chief Development Officer
Transactions
- Award
Common Stock, par value $0.00001 per share
2019-01-03+22,667→ 141,063 total - Award
Stock Option (Right to Buy)
2019-01-03+66,000→ 66,000 totalExercise: $7.58From: 2020-01-03Exp: 2029-01-03→ Common Stock (66,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. 25% of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- [F2]Includes 7,199 shares acquired on November 20, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
- [F3]25% of the shares subject to the option will vest on each anniversary of the grant date.